No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use*
-
Anti-Arrhythmia Agents / adverse effects
-
Arrhythmias, Cardiac / drug therapy
-
Arrhythmias, Cardiac / mortality
-
Biomarkers / blood
-
Disease Progression
-
Exercise Tolerance / drug effects
-
Exercise Tolerance / physiology
-
Heart Failure / blood
-
Heart Failure / drug therapy*
-
Heart Failure / mortality*
-
Heart Failure / physiopathology
-
Humans
-
Neurotransmitter Agents / antagonists & inhibitors*
-
Neurotransmitter Agents / blood
-
Norepinephrine / blood
-
Stroke Volume / drug effects
-
Stroke Volume / physiology
-
Treatment Outcome
-
Vasodilator Agents / therapeutic use
-
Ventricular Function, Left / drug effects*
-
Ventricular Function, Left / physiology
-
Ventricular Remodeling / drug effects
-
Ventricular Remodeling / physiology
Substances
-
Adrenergic beta-Antagonists
-
Anti-Arrhythmia Agents
-
Biomarkers
-
Neurotransmitter Agents
-
Vasodilator Agents
-
Norepinephrine